HCT-CI versus CCI for prediction of 2-year NRM and survival in the validation set
. | HCT-CI . | . | . | . | . | . | CCI . | . | . | . | . | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| . | . | NRM . | . | Survival . | . | . | . | NRM . | . | Survival . | . | ||||||||
| Score . | No. . | HR*(95% CI) . | 2-year, % . | HR*(95% CI) . | 2-year, % . | Score . | No. . | HR*(95% CI) . | 2-year, % . | HR*(95% CI) . | 2-year, % . | ||||||||
| 0 | 38 | 1.0 | 14 | 1.0 | 71 | 0 | 87 | 1.0 | 23 | 1.0 | 59 | ||||||||
| 1 to 2 | 34 | 1.42 (0.8-2.7) | 21 | 1.31 (0.8-2.0) | 60 | 1 | 10 | 1.25 (0.6-2.5) | 29 | 1.32 (0.8-2.2) | 49 | ||||||||
| 3 or more | 28 | 3.54 (2.0-6.3) | 41 | 2.69 (1.8-4.1) | 34 | ≥2 | 3 | 1.46 (0.5-4.7) | 25 | 2.78 (1.4-5.6) | 17 | ||||||||
. | HCT-CI . | . | . | . | . | . | CCI . | . | . | . | . | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| . | . | NRM . | . | Survival . | . | . | . | NRM . | . | Survival . | . | ||||||||
| Score . | No. . | HR*(95% CI) . | 2-year, % . | HR*(95% CI) . | 2-year, % . | Score . | No. . | HR*(95% CI) . | 2-year, % . | HR*(95% CI) . | 2-year, % . | ||||||||
| 0 | 38 | 1.0 | 14 | 1.0 | 71 | 0 | 87 | 1.0 | 23 | 1.0 | 59 | ||||||||
| 1 to 2 | 34 | 1.42 (0.8-2.7) | 21 | 1.31 (0.8-2.0) | 60 | 1 | 10 | 1.25 (0.6-2.5) | 29 | 1.32 (0.8-2.2) | 49 | ||||||||
| 3 or more | 28 | 3.54 (2.0-6.3) | 41 | 2.69 (1.8-4.1) | 34 | ≥2 | 3 | 1.46 (0.5-4.7) | 25 | 2.78 (1.4-5.6) | 17 | ||||||||
Adjusted for age, disease risk, and conditioning.